Biosante Pharmaceuticals, Inc. (NASDAQ:BPAX)

1.76

-0.04 (-2.22%)

1:03EST Delayed

Open
1.85
High
1.85
Low
1.73
Vol.
39.29K
Avg. Vol.
250.60K
Mkt Cap
94.43M
52Wk High
2.70
52Wk Low
1.13
Bid
1.88
Ask
1.89
P/E (Trailing)
Beta
0.60
Short %
6.50%
Div. Yield
Shares
53.65M

Company Profile

Biosante Pharmaceuticals, Inc.

Biosante Pharmaceuticals, Inc.

111 Barclay Boulevard

Lincolnshire, IL 60069

United States - Map

Phone: (847) 478-0500

Fax: (847) 478-9152

Website: www.biosantepharma.com

State of incorporation: Delaware

CEO: Stephen M. Simes

Employees: 23

Sector: Healthcare

Industry Group: Drugs

Industry: Biotechnology

Development stage biopharmaceutical company

A specialty pharmaceutical company, focused on developing products for female sexual health, menopause, contraception and male hypogonadism.

Recent news for BPAX

Members owning BPAX also own

NVDL (40.00%), HBAN (40.00%), BVF (40.00%), SVA (40.00%), HDSN (40.00%)

Member sentiment (?)    Neutral

Recent opinions on BPAX

No recent Opinions for BPAX

Top members owning BPAX

* Average monthly return vs. S&P 500

- Advertisement -